Cargando…

Ranibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis

BACKGROUND: To evaluate the safety of ranibizumab as a surgical adjunct during cataract surgery in patients with proliferative diabetic retinopathy (PDR) with rubeosis, and to evaluate the efficacy and adverse effects of ranibizumab in treating PDR with rubeosis. MATERIALS AND METHODS: Three intravi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Yufei, Fay, Catherine, Guo, Suqin, Zarbin, Marco A., Marcus, Edward, Bhagat, Neelakshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574511/
https://www.ncbi.nlm.nih.gov/pubmed/23439790
http://dx.doi.org/10.4103/0974-620X.106099